BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 24,237 Value ($000) $1,854 Avg Close $65.64 Range $51.85 - $78.44
Q3 2025
Shares 39,849 Value ($000) $2,070 Avg Close $48.77 Range $41.80 - $54.60
Q2 2025
Shares 50,823 Value ($000) $2,195 Avg Close $36.37 Range $28.32 - $45.48
Q1 2025
Shares 50,841 Value ($000) $1,758 Avg Close $33.72 Range $27.53 - $39.47
Q4 2024
Shares 68,700 Value ($000) $1,885 Avg Close $25.84 Range $21.72 - $30.51
Q3 2024
Shares 61,150 Value ($000) $1,557 Avg Close $26.25 Range $23.40 - $32.06
Q2 2024
Shares 23,311 Value ($000) $590 Avg Close $27.34 Range $21.62 - $31.43
Q1 2024
Shares 11,514 Value ($000) $356 Avg Close $34.01 Range $26.82 - $41.04
Q4 2023
Shares 15,254 Value ($000) $616 Avg Close $30.03 Range $23.62 - $44.32
Q3 2023
Shares 15,214 Value ($000) $401 Avg Close $28.38 Range $16.61 - $36.36
Q2 2023
Shares 19,041 Value ($000) $328 Avg Close $15.05 Range $12.75 - $18.18
Q1 2023
Shares 15,277 Value ($000) $253 Avg Close $11.66 Range $7.10 - $19.95
Q4 2022
Shares 23,401 Value ($000) $178 Avg Close $9.57 Range $6.64 - $11.58